This Health Care Software Firm Nears Buy Point After Whopping 101% Year-To-Date Gain

Blockhead12-21 04:20

Health care software play Doximity (DOCS) is quickly approaching a buy point. Shares of the San Francisco-based firm hit a high of 61.75 on Nov. 11 after a positive earnings report, and are up a ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2493479747?lang=en_US&edition=fundamental","thumbnail":"https://www.investors.com/wp-content/uploads/2024/12/Stock-doximity-App-company-150x150.jpg","is_english":true,"pubTime":"2024-12-21 04:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2493479747","market":"sg","top_or_hot":-1,"title":"This Health Care Software Firm Nears Buy Point After Whopping 101% Year-To-Date Gain","media":"Blockhead","content":"<div>\n<p>Health care software play Doximity (DOCS) is quickly approaching a buy point. Shares of the San Francisco-based firm hit a high of 61.75 on Nov. 11 after a positive earnings report, and are up a ...</p>\n\n<a href=\"https://www.investors.com/stock-lists/sector-leaders/doximity-stock-docs-stock-health-care-software/\">Source Link</a>\n\n</div>\n","source":"investor_business_daily_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Health Care Software Firm Nears Buy Point After Whopping 101% Year-To-Date Gain</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Health Care Software Firm Nears Buy Point After Whopping 101% Year-To-Date Gain\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-21 04:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.investors.com/stock-lists/sector-leaders/doximity-stock-docs-stock-health-care-software/><strong>Blockhead</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Health care software play Doximity (DOCS) is quickly approaching a buy point. Shares of the San Francisco-based firm hit a high of 61.75 on Nov. 11 after a positive earnings report, and are up a ...</p>\n\n<a href=\"https://www.investors.com/stock-lists/sector-leaders/doximity-stock-docs-stock-health-care-software/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://www.investors.com/stock-lists/sector-leaders/doximity-stock-docs-stock-health-care-software/","article_id":"2493479747","we_media_id":null,"thumbnails":["https://www.investors.com/wp-content/uploads/2024/12/Stock-doximity-App-company-150x150.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2493479747","pubTimestamp":1734726054,"columns":[],"sourceInfo":{"source_id":"investor_business_daily_highlight","name":"Investor’s Business Daily"},"weMediaInfo":null,"summary":"Doximity stock jumped over 34% following its most recent earnings report on Nov. 11. Now, shares are nearing a buy point.","collect":0,"end_time":0,"defaultTopTitle":"investors.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","BK4539":"次新股","BK4167":"医疗保健技术","BK4551":"寇图资本持仓","BK4585":"ETF&股票定投概念","DOCS":"Doximity, Inc."},"translate_title":"这家医疗保健软件公司今年迄今上涨101%，接近买入点","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DOCS":1},"content_text":"Health care software play Doximity (DOCS) is quickly approaching a buy point. Shares of the San Francisco-based firm hit a high of 61.75 on Nov. 11 after a positive earnings report, and are up a whopping 101% year to date.\n\n\n\n↑\nX\n\n\n\n\nHow To Adapt Trading Strategies To Fit A Time Frame That Works For You\n\n\nSee All Videos\n\n\n\n\nNOW PLAYING\nHow To Adapt Trading Strategies To Fit A Time Frame That Works For You\n\n\n\n\nDoximity operates a cloud-based digital platform for medical professionals in the U.S. The platform enables members to collaborate with colleagues, manage their on-call schedules, streamline administrative paperwork and conduct virtual patient visits. The company also provides artificial-intelligence assistants.\nThe stock has been barreling higher this year, especially in August. Shares catapulted more than 31% during the week ended Aug. 9, thanks to a very strong earnings report. Another strong earnings report Nov. 7 had the stock rise over 37% that week.\nThe very next week, the stock reached a high of 61.75, which coincides with the current buy point, before sliding into a price consolidation. Despite the pullback, the stock has managed to remain above the 21-day moving average, a sign of strength. Aggressive investors could use the Dec. 6 high at 56.67 as an early entry.\n\nWith a perfect 99 Composite Rating and strong 97 Relative Strength Rating, Doximity checks several boxes both fundamentally and technically. It also ranks No. 1 in Investor's Business Daily's medical software industry group, reflecting its leadership qualities. The group itself ranks No. 45 out of IBD's 197 groups.\nGrowth Path For Doximity Stock\nOn Nov. 7, Doximity reported results for its second quarter and the market was very happy with the results. Doximity grew sales and earnings per share by 20% and 36%, respectively. Additionally, guidance improved for the full year.\nThe company has seen a nice acceleration in revenue growth over the last three quarters, from 6% to 17% and 20% in the most recent quarter.\nAnalysts expect earnings growth to continue in 2025 and 2026, with EPS increases of 21% and 10%, respectively, according to IBD MarketSurge.\nOther impressive markers include its handling of over 1 million prompts in Q2 from its Doximity GPT solution. This allows for physicians to do less paperwork. The platform is now used by over 80% of U.S. physicians, 60% of nurse practitioners and 90% of graduating med students.\n\"Our clinical workflow tools saw record use in Q2 with over 600,000 unique active prescribers,\" said Jeff Tangney, cofounder and CEO of Doximity, in a recent news release. \"We're proud to help physicians save time, so they can provide better care for their patients.\"\nYOU MAY ALSO LIKE:\nStocks With Rising Relative Strength Ratings\nGet Full Access To IBD Stock Lists And Ratings\nWhy Should You Use IBD's Relative Strength Rating?\nHow relative strength line Can Help You Judge A Stock\nFind Top Stocks Near A Buy Point With IBD Leaderboard","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2493479747"}